IRadimed
IRMD
#5577
Rank
A$1.85 B
Marketcap
A$145.71
Share price
1.34%
Change (1 day)
71.93%
Change (1 year)
Categories

Earnings for IRadimed (IRMD)

Earnings in 2025 (TTM): A$41.9 Million

According to IRadimed's latest financial reports the company's current earnings are A$80.51 Million. In 2024 the company made an earning of A$36.55 Million, an increase over its 2023 earnings that were of A$32.73 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for IRadimed from 2013 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) A$41.9 M14.63%
2024 A$36.55 M11.67%
2023 A$32.73 M34.35%
2022 A$24.36 M64.5%
2021 A$14.81 M-1694.53%
2020 -A$0.93 Million-106.82%
2019 A$13.61 M45.92%
2018 A$9.33 M343.81%
2017 A$2.1 M-87.25%
2016 A$16.49 M-5.86%
2015 A$17.52 M285.59%
2014 A$4.54 M8.39%
2013 A$4.19 M

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
AtriCure
ATRC
-A$33.13 Million-181.74%๐Ÿ‡บ๐Ÿ‡ธ USA
NuVasive
NUVA
A$91.74 M 126.36%๐Ÿ‡บ๐Ÿ‡ธ USA
DexCom
DXCM
A$1.47 B 3,533.69%๐Ÿ‡บ๐Ÿ‡ธ USA
Edwards Lifesciences
EW
A$2.57 B 6,242.24%๐Ÿ‡บ๐Ÿ‡ธ USA